
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4
Mingying Li, Jingjing Ye, Xia Yuan, et al.
Leukemia (2022) Vol. 36, Iss. 11, pp. 2586-2595
Open Access | Times Cited: 50
Mingying Li, Jingjing Ye, Xia Yuan, et al.
Leukemia (2022) Vol. 36, Iss. 11, pp. 2586-2595
Open Access | Times Cited: 50
Showing 1-25 of 50 citing articles:
Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
Yanan Qi, Zhu Liu, Lian‐Lian Hong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 60
Yanan Qi, Zhu Liu, Lian‐Lian Hong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 60
The role of RNA methylation in tumor immunity and its potential in immunotherapy
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 32
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 32
Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Advances in targeting RNA modifications for anticancer therapy
Monica Pomaville, Chuan He
Trends in cancer (2023) Vol. 9, Iss. 7, pp. 528-542
Open Access | Times Cited: 30
Monica Pomaville, Chuan He
Trends in cancer (2023) Vol. 9, Iss. 7, pp. 528-542
Open Access | Times Cited: 30
EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway
Xinyu Yang, Fengjiao Han, Xiang Hu, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Xinyu Yang, Fengjiao Han, Xiang Hu, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Small molecule inhibitors targeting m6A regulators
Guotai Feng, Yongya Wu, Yuan Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 12
Guotai Feng, Yongya Wu, Yuan Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 12
Immunotherapeutic targeting of surfaceome heterogeneity in AML
Marie-Ève Bordeleau, Éric Audemard, Arnaud Métois, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114260-114260
Open Access | Times Cited: 10
Marie-Ève Bordeleau, Éric Audemard, Arnaud Métois, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114260-114260
Open Access | Times Cited: 10
Human immune organoids to decode B cell response in healthy donors and patients with lymphoma
Zhong Zhe, Manuel Quiñones-Pérez, Zhonghao Dai, et al.
Nature Materials (2024)
Closed Access | Times Cited: 9
Zhong Zhe, Manuel Quiñones-Pérez, Zhonghao Dai, et al.
Nature Materials (2024)
Closed Access | Times Cited: 9
Suppression of the METTL3-m6A-integrin β1 axis by extracellular acidification impairs T cell infiltration and antitumor activity
Zhe Wang, Jingzhe Shang, Yajing Qiu, et al.
Cell Reports (2024) Vol. 43, Iss. 2, pp. 113796-113796
Open Access | Times Cited: 8
Zhe Wang, Jingzhe Shang, Yajing Qiu, et al.
Cell Reports (2024) Vol. 43, Iss. 2, pp. 113796-113796
Open Access | Times Cited: 8
Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia
Shengnan Guo, Gopi S. Mohan, Bofei Wang, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 2, pp. e008318-e008318
Open Access | Times Cited: 5
Shengnan Guo, Gopi S. Mohan, Bofei Wang, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 2, pp. e008318-e008318
Open Access | Times Cited: 5
HDAC1/3-dependent moderate liquid–liquid phase separation of YY1 promotes METTL3 expression and AML cell proliferation
Meng Li, Mingying Li, Xia Yuan, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 20
Meng Li, Mingying Li, Xia Yuan, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 20
The relevance of the hematopoietic niche for therapy resistance in acute myeloid leukemia
Catana Allert, Carsten Müller‐Tidow, Maximilian Felix Blank
International Journal of Cancer (2023) Vol. 154, Iss. 2, pp. 197-209
Open Access | Times Cited: 12
Catana Allert, Carsten Müller‐Tidow, Maximilian Felix Blank
International Journal of Cancer (2023) Vol. 154, Iss. 2, pp. 197-209
Open Access | Times Cited: 12
Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance
Hyein Jo, Kyeonghee Shim, Dooil Jeoung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4225-4225
Open Access | Times Cited: 11
Hyein Jo, Kyeonghee Shim, Dooil Jeoung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4225-4225
Open Access | Times Cited: 11
Comprehensive analysis of m6A methylome alterations after azacytidine plus venetoclax treatment for acute myeloid leukemia by nanopore sequencing
Zaifeng Zhang, Lili Zhang, Jiangtao Li, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 1144-1153
Open Access | Times Cited: 4
Zaifeng Zhang, Lili Zhang, Jiangtao Li, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 1144-1153
Open Access | Times Cited: 4
Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy
Angel Guan, Justin Wong
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 4
Angel Guan, Justin Wong
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 4
Rhein exerts anti-multidrug resistance in acute myeloid leukemia via targeting FTO to inhibit AKT/mTOR
Shuling Zhang, Lanxia Zhou, Jincai Yang, et al.
Anti-Cancer Drugs (2024)
Closed Access | Times Cited: 4
Shuling Zhang, Lanxia Zhou, Jincai Yang, et al.
Anti-Cancer Drugs (2024)
Closed Access | Times Cited: 4
ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation
Jiaxing Zhang, Gang Wang, Jie Liu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Jiaxing Zhang, Gang Wang, Jie Liu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Role of integrin α4 in the inhibition of fibrosis in activated hepatic stellate cells by Periplaneta americana extract
Ying Fang, Ye Liu, Dingchun Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Ying Fang, Ye Liu, Dingchun Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Methyltransferase-like 3-mediated RNA N6-methyladenosine contributes to immune dysregulation: diagnostic biomarker and therapeutic target
Deshuang Zhang, Ting Xu, Xiaoxue Gao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Deshuang Zhang, Ting Xu, Xiaoxue Gao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Targeting METTL3 mitigates venetoclax resistance via proteasome-mediated modulation of MCL1 in acute myeloid leukemia
Cheng Jiao, Chen Hu, Meng-Hua Sun, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Cheng Jiao, Chen Hu, Meng-Hua Sun, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Summary of the mechanism of ferroptosis regulated by m6A modification in cancer progression
Bin Fan, Gangxian Chen, Shu‐Yi Huang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Bin Fan, Gangxian Chen, Shu‐Yi Huang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Machine learning approaches reveal methylation signatures associated with pediatric acute myeloid leukemia recurrence
Yushuang Dong, HuiPing Liao, FeiMing Huang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Yushuang Dong, HuiPing Liao, FeiMing Huang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
N6‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis
Li Song, Jianyuan Zhou, Shuang Wang, et al.
Cancer Communications (2025)
Open Access
Li Song, Jianyuan Zhou, Shuang Wang, et al.
Cancer Communications (2025)
Open Access
Interpreting single-cell messages in normal and aberrant hematopoiesis with the Cell Marker Accordion
Emma Busarello, Giulia Biancon, Ilaria Cimignolo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Emma Busarello, Giulia Biancon, Ilaria Cimignolo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
A new perspective on hematological malignancies: m6A modification in immune microenvironment
Shiyu Yang, Liping Xu, Haihui Zhuang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Shiyu Yang, Liping Xu, Haihui Zhuang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3